These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7849341)

  • 1. New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis.
    Rapp RP; McCraney SA; Goodman NL; Shaddick DJ
    Ann Pharmacother; 1994 Nov; 28(11):1255-63. PubMed ID: 7849341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles.
    Sturgill MG; Rapp RP
    Ann Pharmacother; 1992 Sep; 26(9):1099-108. PubMed ID: 1421677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S; Enzler MJ
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin.
    Tartaglione T
    Clin Ther; 1997; 19(4):626-38; discussion 603. PubMed ID: 9377608
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sun Q; Liao X; Wang C; Jiang G; Yang J; Zhao J; Huang H; Wang G; Li H
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708979
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance.
    Choi GE; Shin SJ; Won CJ; Min KN; Oh T; Hahn MY; Lee K; Lee SH; Daley CL; Kim S; Jeong BH; Jeon K; Koh WJ
    Am J Respir Crit Care Med; 2012 Nov; 186(9):917-25. PubMed ID: 22878281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
    Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
    HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
    Bahal N; Nahata MC
    Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin and clarithromycin: overview and comparison with erythromycin.
    Whitman MS; Tunkel AR
    Infect Control Hosp Epidemiol; 1992 Jun; 13(6):357-68. PubMed ID: 1320067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of azithromycin and clarithromycin in clinical practice.
    Goldman MP; Longworth DL
    Cleve Clin J Med; 1993; 60(5):359-64. PubMed ID: 8403355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
    Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E
    Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
    Tebas P; Sultan F; Wallace RJ; Fraser V
    Clin Infect Dis; 1995 Feb; 20(2):443-4. PubMed ID: 7742453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
    Kawahara S; Nagare H
    Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and prophylaxis of Mycobacterium avium complex.
    Young LS
    Int J STD AIDS; 1996; 7 Suppl 1():23-7. PubMed ID: 8652724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection.
    Tanaka E; Kimoto T; Tsuyuguchi K; Suzuki K; Amitani R
    J Infect Chemother; 2002 Sep; 8(3):252-5. PubMed ID: 12373490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in the treatment of nontuberculous mycobacterial (NTM) disease.
    Griffith DE; Wallace RJ
    Semin Respir Infect; 1996 Dec; 11(4):301-10. PubMed ID: 8976583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus.
    Maurer FP; Castelberg C; Quiblier C; Böttger EC; Somoskövi A
    J Antimicrob Chemother; 2014 Jun; 69(6):1559-63. PubMed ID: 24500188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium chelonae: nonhealing leg ulcers treated successfully with an oral antibiotic.
    Terry S; Timothy NH; Zurlo JJ; Manders EK
    J Am Board Fam Pract; 2001; 14(6):457-61. PubMed ID: 11757889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC; Danziger LH; Rodvold KA
    Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.